Autism Assessment
Children will be assessed as early as 18 months for an autism diagnosis. At 24 months, children will receive rigorous and standardized autism diagnostic evaluations. Although these assessments occur at the Columbia University Irving Medical Center campus, the Assessment Core is headed by experts located at the Center for Autism and the Developing Brain (CADB), located in White Plains, New York.
Project Lead
Stephen M. Kanne, PhD
- Professor of Psychology in Clinical Psychiatry
Stephen M. Kanne is the Director of the Center for Autism and the Developing Brain and an Assistant Professor of Psychology in Clinical Psychiatry (interim) at Weill Cornell Medical College and New York-Presbyterian Hospital. He received his bachelor’s degree and his doctoral degree in clinical psychology from Washington University. He completed a clinical internship at the University of California, San Diego, followed by a post-doctoral fellowship in Pediatric Neuropsychology at the University of Missouri-Columbia. Dr. Kanne’s current research interests focus on children with Autistic Spectrum Disorders, targeting diagnostic tools, outcome measures, behavioral phenotyping, co-occurring symptoms, evidence-based therapies, and subthreshold symptoms. In addition to publishing in the areas of autism, Dr. Kanne has also published in the areas of cognitive neuropsychology, history of neuropsychology, and pediatric traumatic brain injury.
Faculty
Rebecca Muhle, MD, PhD
- Assistant Professor of Psychiatry
Dr. Muhle earned her medical and graduate degrees from the Medical Scientist Training Program at the Albert Einstein College of Medicine, and completed her adult psychiatry residency and child & adolescent fellowship training within the Solnit Integrated Adult and Child & Adolescent Psychiatry Research Training Program at the Yale University Child Study Center. Dr. Muhle’s scientific research aims to uncover molecular genetic pathways that increase risk for neurodevelopmental disorders such as autism, by utilizing high-throughput genomics methods in mouse and human model systems to examine the effects of disruptions of implicated risk genes. Dr. Muhle is a board-certified general and child & adolescent psychiatrist, with a clinical focus on people who are on the autism spectrum.